Diagnostic Criteria for Hypothyroidism
Overt hypothyroidism is diagnosed when TSH is elevated (typically >10 mIU/L) with a low free T4 (<0.8 ng/dL or 10.3 pmol/L), while subclinical hypothyroidism requires an elevated TSH (>4.5 mIU/L) with normal free T4 (0.8-2.0 ng/dL or 10.3-25.7 pmol/L). 1, 2
Overt Hypothyroidism
The diagnosis is straightforward when both criteria are met:
- TSH elevated above normal range (generally >10 mIU/L indicates more severe disease)
- Free T4 below reference range (<0.8 ng/dL or <10.3 pmol/L) 1, 2
In some cases, patients with hypothyroid symptoms and TSH >10 mIU/L but low-normal free T4 have also been classified as having overt hypothyroidism 1. This reflects the clinical reality that symptomatic patients with markedly elevated TSH warrant treatment even if free T4 hasn't yet fallen below the reference range.
Subclinical Hypothyroidism
This diagnosis requires both of the following:
- TSH above 4.5 mIU/L (the upper limit of the normal reference range of 0.45-4.5 mIU/L) 1
- Free T4 within normal range (0.8-2.0 ng/dL or 10.3-25.7 pmol/L) 1
Critical Diagnostic Considerations
Confirm the diagnosis before labeling a patient: If initial TSH is elevated, repeat TSH along with free T4 measurement at minimum 2 weeks but no longer than 3 months after initial assessment 1. This is essential because TSH can be transiently elevated in approximately 50% of cases, with spontaneous normalization occurring 3.
The TSH range of 2.5-4.5 mIU/L is controversial. While this may identify individuals with earliest-stage hypothyroidism or Hashimoto's thyroiditis, there is no evidence for associated adverse consequences. This range can also reflect technical assay problems, abnormal TSH isoforms, or heterophilic antibodies 1. Do not diagnose subclinical hypothyroidism in this range without compelling clinical context.
Severity Stratification in Subclinical Hypothyroidism
The degree of TSH elevation matters clinically:
- TSH 4.5-10 mIU/L: Mild subclinical hypothyroidism; approximately 75% of patients with elevated TSH fall in this range 1
- TSH >10 mIU/L: More severe subclinical hypothyroidism with stronger indication for treatment 1, 4
Essential Exclusions Before Diagnosis
Rule out these conditions that can falsely elevate TSH:
- Assay interference (occurs in ~1% of cases): human antimouse antibodies (HAMA), thyroid hormone autoantibodies, rheumatoid factor, biotin supplementation 5, 6
- Nonthyroidal illness (euthyroid sick syndrome) 1
- Recent treatment for hyperthyroidism (delayed TSH recovery) 1
- Medications: dopamine, glucocorticoids, dobutamine 1
- Thyroid hormone resistance (check serum α-GSU and family history) 5
- Central hypothyroidism (TSH may be normal or slightly elevated, but free T4 is low) 2
Biotin is a critical pitfall: This common supplement interferes with immunoassays, causing falsely high T4/T3 and low TSH, potentially masking true hypothyroidism or creating false diagnoses. Patients should discontinue biotin at least 2-3 days before testing 5.
Diagnostic Algorithm
- Measure TSH first in at-risk patients
- If TSH >4.5 mIU/L: Measure free T4
- If free T4 is low: Diagnose overt hypothyroidism
- If free T4 is normal: Repeat TSH and free T4 in 2 weeks to 3 months to confirm persistent elevation 1
- If TSH remains elevated on repeat testing:
- Check for symptoms of hypothyroidism
- Assess for goiter, prior thyroid treatment, family history
- Consider measuring anti-TPO antibodies (predicts 4.3% annual progression to overt disease vs 2.6% without antibodies) 1
- Review medications and supplements (especially biotin)
- Ensure same laboratory and assay method for serial measurements 5
Special Populations
Elderly patients (>70 years): TSH levels physiologically increase with age. The diagnosis of subclinical hypothyroidism is likely overdiagnosed and overtreated in this population 3. Consider higher TSH thresholds before diagnosing disease.
Pregnant women: Require different TSH reference ranges specific to trimester and warrant special diagnostic and treatment considerations 7.
Epidemiology Context
Subclinical hypothyroidism affects 4-8.5% of the U.S. adult population without known thyroid disease, increasing to 20% in women over 60 years 1. Progression to overt hypothyroidism occurs in 2-5% annually, with higher rates when TSH is elevated and anti-TPO antibodies are present 1, 4.